Financhill
Back

Candel Therapeutics, Inc. Vs. Nebius Group NV Industry Stock Comparison

Buy
52

CADL
Candel Therapeutics, Inc.

Last Price:
$5.56
Seasonality Move:
2.55%
Sell
42

NBIS
Nebius Group NV

Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
52
Candel Therapeutics, Inc. (CADL) is a Buy

Is Candel Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Candel Therapeutics, Inc. [CADL] share price is $5.57. The Score for CADL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CADL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CADL Stock Price Chart

What is Candel Therapeutics, Inc.'s stock price today?

  • The Candel Therapeutics, Inc. share price today is $5.57
    The current trend is moderately bullish and CADL is experiencing slight selling pressure.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $89.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CADL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 54.34 Buy
Chaikin Money Flow: -162234 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.51 - 5.75) Buy
Bollinger Bands (100): (4.87 - 5.97) Buy

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 47.32 Sell
Chaikin Money Flow: 13904832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.34 - 98.02) Sell
Bollinger Bands (100): (72.32 - 115.66) Sell

CADL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.84 Sell
20-day SMA: 5.27 Buy
50-day SMA: 5.26 Buy
200-day SMA: 5.64 Sell
8-day EMA: 5.64 Sell
20-day EMA: 5.43 Buy
50-day EMA: 5.31 Buy
200-day EMA: 5.63 Sell

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.08 Buy
20-day SMA: 91.37 Sell
50-day SMA: 102.98 Sell
200-day SMA: 65.21 Buy
8-day EMA: 85.42 Buy
20-day EMA: 90.53 Sell
50-day EMA: 95.55 Sell
200-day EMA: 73.6 Buy

Candel Therapeutics, Inc. Earnings Growth & CADL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.11 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Candel Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):